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Abstract 
Aim of this study was to verify whether Mueller-Hinton agar supplemented with 2% glucose and 
methylene blue (MH-GM), which is used for disk diffusion susceptibility testing of Candida 
species by the Clinical and Laboratory Standards Institute, is suitable for testing Malassezia 
pachydermatis. A variant of the disk diffusion procedure utilizing a 9-mm tablet was used to test 31 
isolates against clotrimazole and miconazole using MH-GM as test medium. The MH-GM agar 
optimally supported the growth of all M. pachydermatis isolates provided that the yeast inoculum 
was prepared with a lipid source (Tween 40 and 80). Zone edges were frequently definite and clear, 
facilitating the measurement of zone size and minimizing subjectivity. The inhibition zones 
correlated with MIC values obtained in a broth dilution assay.  
The agar diffusion method with MH-GM as the test medium appears as a suitable screening 
procedure for testing the susceptibility of M. pachydermatis to CTZ and MCZ in clinical 
laboratories. This test format may allow processing a large number of isolates in epidemiological 
studies. This may in turn facilitate clarifying to what extent the problem “drug resistance” accounts 
for cases of treatment failure in dogs with Malassezia otitis and dermatitis. 
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1. Introduction 
Malassezia pachydermatis, the sole lipophilic, but not lipid-dependent, species of Malassezia, is a 
normal inhabitant of canine skin and ear canals. Favorable growth conditions in the local skin 
environment allow excessive multiplication of this organism, which may then function as an 
opportunistic secondary pathogen in dermatitis and otitis externa [1].  
Canine Malassezia dermatitis and otitis have been reported to be responsive to a variety of 
antifungal medications, including azole derivatives, nystatin, and terbinafine [2]. However, 
treatment failure is commonly reported in clinical practice, especially for otitis, and whether failure 
is due to incorrect management of conditions underlying the yeast overgrowth or antifungal 
resistance of the yeast is unclear. Some studies support the latter possibility, reporting isolate 
resistance to commonly used drugs, such as thiabendazole, clotrimazole, miconazole, and 
itraconazole[3–6]. However, other studies have reported substantial activity for these drugs [7–10]. 
Such discrepancies are due to the fact that in vitro susceptibility tests are still largely unstandardized 
with regard to M. pachydermatis. Thus, this issue would benefit from the development of a testing 
method capable of standardization and routine application in testing a large number of Malassezia 
isolates.  
A disk diffusion procedure has been standardized for Candida species by the Clinical and 
Laboratory Standards Institute (CLSI, document M44-A2) [11]. The precision of this method can be 
compared to that of minimum inhibitory concentration (MIC, µg/ml) determinations using the 
reference broth dilution-based assay for testing the antifungal susceptibility of yeasts (CLSI 
document M27-A3)[12,13].Compared with this reference procedure, the disk diffusion method has 
been shown to be more user-friendly and practical [13]. Most studies of the antifungal susceptibility 
of M. pachydermatis have been based on broth dilution procedures. As mentioned, these studies 
have not yet led to establishing a reference procedure, but they at least allowed a definition of 
technical parameters that may be suitable for this type of assay [7,10,14–24]. On the other hand, the 
value of agar diffusion procedures has been investigated less comprehensively, with a minority of 
 4 
 
studies employing such methodology [4,5,7,9,10]. In addition, no study has ever demonstrated 
whether inhibition zones correlate with MIC values as has been done with Candida spp. and other 
yeast species[13,26]. Moreover, the growth media employed for agar diffusion testing of M. 
pachydermatis (Sabouraud dextrose agar - SDA [6,9], SDA with 1% Tween 80 and 1.5% yeast 
extract [4], Casitone agar [3,8]), were not evaluated with regard to their fitness in producing clear 
and easy to interpret inhibition zone edges. Yet, this issue has an obvious impact on the accuracy of 
reading and, consequently, the repeatability of results [26,27]. The CLSI reference assay (document 
M44-A2) uses Mueller-Hinton (MH) agar supplemented with 2% glucose (G) and methylene blue 
(M), since it produces clear inhibition zone edges and less intrazonal growth, enabling easy 
interpretation of inhibition zone diameters [11]. In a recent publication, MH-GM agar has been used 
for the first time also for testing M. pachydermatis, in particular towards ketoconazole, itraconazole, 
nystatine, terbinafine and 5-fluorocytosine [25]. The aim of the present study was to contribute to 
ascertain the suitability of this medium  for susceptibility testing of M. pachydermatis using other 
two drugs of common use in the dog, namely clotrimazole and miconazole. 
2. Materials and methods 
Clotrimazole (CTZ) and miconazole (MCZ) were tested against 31 clinical isolates of M. 
pachydermatis, including a reference strain (M. pachydermatis CBS 1879) for which we previously 
found a range of MICs for both drugs [10]. We used a variant of the disk diffusion procedure that 
utilizes a 9-mm tablet (NeoSensitabs, 10 µg diffusible amount; Rosco, Taastrup, Denmark) and has 
been favorably investigated for testing Candida spp. [28] The method was performed according to 
the manufacturer’s instructions and M44-A2 guidelines [11]. Uniform yeast suspensions were 
prepared in the culture medium used for the broth dilution assay (Christensen’s urea broth with 
Tween 80 and Tween 40 as the lipid source) and vortexed with glass beads to avoid yeast cell 
clustering. Inoculum suspensions were adjusted by spectrophotometry to approximately 1–5 × 107 
colony-forming units (cfu)/ml. Lower-concentration inoculums, such as that recommended by CLSI 
for Candida spp. (0.5 McFarland standard, corresponding to 1 × 106 - 5 × 106 cfu/ml) [11] and 
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suspensions without a lipid source, e.g prepared in sterile saline, were shown to not provide 
adequate confluent growth of Malassezia on agar plates in preliminary experiments (data not 
shown).  
3. MH agar (Biolife Italiana S.r.l, Milan, Italy) was solidified after the addition of 2% glucose 
and 5 mg methylene blue/ml (Sigma Aldrich, Milan, Italy). GM-MH agar plates (150-mm 
plates) were inoculated simultaneously in three directions using a nontoxic cotton swab 
dipped in the inoculum suspension. After the plates were dried for 15 min, CTZ and MCZ 
tablets were applied to the inoculated agar with a pair of forceps. The plates were incubated 
in ambient air at 37°C. The diameter of each zone of inhibition was determined as the area 
showing a sharp decline in the density of growth (CLSI, 2009). For the broth-dilution assay 
we used a modified CLSI M27-A3 microdilution method (CLSI, 2008), which was 
described previously [10]. Briefly, a 96-well microtiter plate containing progressive 
dilutions of the antifungals across rows (16-0.03 µg/ml) was inoculated with the yeast 
culture (1:100 dilution of the suspension used in the tablet diffusion method, final inoculum 
1-5 × 105 cfu/ml). The test medium was Christensen’s urea broth with Tween 80 and Tween 
40 as the lipid source in accordance with Rincon et al. (2006) [15], who showed that this 
medium optimally supports the growth of Malassezia spp. and does not interfere with 
antifungal activity. Plates were incubated at 37°C and read 48 h after inoculation. Azole 
MICs were the lowest drug concentrations showing an optical density of ≤50% of the drug-
free growth control as assessed by spectrophotometry (630 nm filter) [12]. Zones of 
inhibition were plotted against the MICs determined by the microdilution method and the 
least-squares method was used to calculate regression lines. The correlation between 
diameters and MICs was evaluated by the Spearman test. Results 
The MH-GM agar optimally supported the growth of all M. pachydermatis isolates tested. Zone 
edges were frequently definite and clear. The methylene blue gave the agar plates a slight blue color 
and offered better contrast between the growth/no growth zone, facilitating the measurement of 
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zone size and minimizing subjectivity (Fig. 1). During the first 24 h, most strains grew too poorly to 
permit measurement of zone diameters, but they all grew sufficiently after 48 h. Zone diameters at 
72 h and subsequent controls (up to 5 days) were unmodified. Therefore, we chose 48 h as the time 
of reading.  
Table 1 presents the inhibition zone diameters corresponding to each MIC obtained in the broth-
dilution assay. MIC diameters were generally wider around CTZ tablets, but the same tendency was 
noted for both drugs, namely increased MIC was accompanied by a progressive decrease in the 
diameter of the inhibition zone. This tendency was confirmed by regression statistics calculated 
from a scattergram plotted to compare the 48-h inhibition zones and the microdilution MICs for 
each of the 31 strains (Fig. 2). From the regression lines calculated, a two-fold concentration change 
in MICs was accompanied by about 6 (CTZ) and 3 mm (MCZ) change in the diameter of the zone 
of inhibition. Moreover, Spearman correlation test yielded a significant negative correlation 
between MIC values and diameters of inhibition both for CTZ (rho= - 0.59; p< 0.05) and MCZ 
(rho= - 0.55; p< 0.05). The mean intra-assay coefficient of variation was 5.1% and 4.4% for CTZ 
and MCZ, respectively, indicating good reproducibility of the results for both drugs.  
4. Discussion 
The present study was aimed to set up laboratory parameters adequate to obtain reliable indications 
on the in vitro susceptibility of M. pachydermatis to two azole drugs, CTZ and MCZ, using an agar 
diffusion procedure. In particular we focused on the growth medium, which is recognized to play a 
key role for this type of test [13,27,29]. The MH-GM medium employed is recommended by the 
CLSI for testing Candida species in disk diffusion assay [11]. Indeed, several multicenter studies 
have shown that this medium is superior to other agars because it is readily available, shows 
acceptable batch-to-batch reproducibility, and produces clear inhibition zone edges and less 
intrazonal growth, enabling easy interpretation of inhibition zone diameters [29]. Our findings 
support the validity of  this agar also for susceptibility testing of M. pachydermatis with agar 
diffusion procedures,  provided that the yeast inoculum is prepared with a lipid source (Tween 40 
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and Tween 80 in the present study). In particular, the production of clear and reproducible 
inhibition zones that correlate with MIC values suggest that the agar diffusion method with MH-
GM agar can be used as a screening procedure for the susceptibility of M. pachydermatis to CTZ 
and MCZ in clinical laboratories. This test format, more simple and rapid than the broth 
microdilution procedure, may allow processing a higher number of isolates in epidemiological 
studies. This may in turn facilitate clarifying to what extent the problem “drug resistance” accounts 
for cases of treatment failure in dogs with Malassezia otitis and dermatitis that undergo antifungal 
treatment with CTZ and MCZ.  The use of MH-GM rather than of SDA, employed in past studies 
of M. pachydermatis using the disk diffusion method [4,6,9] might be preferable. Indeed, SDA has 
been reported, even though in a different test format (agar dilution assay), to obfuscate the 
antifungal activity of some antifungal agents, such as 5-fluorocytosine, CTZ, and MCZ [30,31]. 
In a recent study, Yurayart et al. [25] employed a disk diffusion procedure with MH-GM agar as 
growth medium for testing M. pachydermatis against other azole drugs – ketoconazole and 
itraconazole – and drugs belonging to other chemical classes, such as nystatine, terbinafine and 5-
fluorocytosine. Unfortunately, this study does not document clearly the performances of MH-GM 
medium. Moreover most results are reported in a way difficult to interpret. For example, authors say 
that “Mueller Hinton agar supplemented with 2% dextrose and 0.5 mg/l methylene blue was used 
for disk diffusion method to allow growth of M. pachydermatis and clearly presented an inhibition 
zone, except for KTZ and ITZ” [25]. Also the correlation of inhibition zones with MIC values is not 
clear, given that in the diagrams presented in this publication [25] a very low MIC value on the x-
axis (< 0,03) appears to correspond on the y-axis to a wide range of inhibition diameters (from 
about 20 to 80 mm for itraconazole; from 25 to 90 mm for ketoconazole). Reading of the text does 
not contribute clarifying this issue, since authors report that “the scatter diagrams and the statistical 
analysis using linear regression could not explain the correlation between the CLSI MICs and 
inhibition zone diameters due to a lack of diversity among the susceptibility levels of M. 
pachydermatis”[25].  
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In conclusion, the present study documents clearly for the first time the suitability of MH-GM agar 
for agar diffusion susceptibility testing of M. pachydermatis, at least as far as CTZ and MCZ are 
concerned. Further experiments will be necessary to confirm the suitability of this medium for 
testing the activity of other antifungal agents. 
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FIGURE LEGENDS 
Fig. 1. MCZ disk diffusion assay for a Malassezia pachydermatis strain, performed on Mueller-
Hinton agar supplemented with 2% glucose and methylene blue. A clear inhibition zone edge is 
visible. 
 
Fig. 2. Zones of inhibition around 10-µg clotrimazole or miconazole tablets plotted against the 
MICs determined by the microdilution method for 31 isolates of Malassezia pachydermatis. The 
least-squares method was used to calculate regression lines (y = 63.6 – 5.59x, with R2 = 0.4 for 
CTZ; y = 43.2 – 3.03x, with R2 = 0.52 for MCZ) 
 
 
